New study shows COVID-19 vaccination linked to fewer cardiac events
A health worker administers a COVID-19 vaccine shot to a local resident in Los Angeles, the United States, on Dec. 17, 2022. (Xinhua)
"While we cannot attribute causality, it is supportive evidence that vaccination may have beneficial effects on a variety of post-COVID-19 complications," a researcher said.
LOS ANGELES, Feb. 20 (Xinhua) -- New research suggests that vaccination against COVID-19 is associated with fewer heart attacks, strokes, and other cardiovascular issues among people who were infected with SARS-CoV-2, the virus that causes COVID-19.
The study, published Monday in the Journal of the American College of Cardiology, is the first to examine both full and partial vaccination and the link to major adverse cardiac events (MACE) in the United States.
Researchers from the Icahn School of Medicine at Mount Sinai used the U.S. National COVID Cohort Collaborative database. The study included 1,934,294 patients, 217,843 of whom received mRNA vaccine formulations by Pfizer-BioNTech or Moderna or viral vector technology by Johnson &Johnson.
"We sought to clarify the impact of previous vaccination on cardiovascular events among people who develop COVID-19 and found that, particularly among those with comorbidities, such as previous MACE, type 2 diabetes, high cholesterol, liver disease, and obesity, there is an association with a lower risk of complications," said senior author Girish N. Nadkarni, professor of medicine at the Icahn School of Medicine at Mount Sinai.
"While we cannot attribute causality, it is supportive evidence that vaccination may have beneficial effects on a variety of post-COVID-19 complications," he said.
Photos
Related Stories
- U.S. starts trial to evaluate antiviral in adults hospitalized with COVID-19
- China's optimized COVID response revives holiday travel buzz
- California COVID-19 cases top 12 million: report
- Vaccines from China bolster COVID fight
- China's adjustment of COVID-19 response to boost global growth in 2023: Goldman Sachs
Copyright © 2023 People's Daily Online. All Rights Reserved.